Eric Benevich - 01 May 2025 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Reporting relationship: Director
Issuer ticker: ATYR
Reported as of: 01 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 May 2025, 17:18:49 UTC
Prior SEC filing: 14 Feb 2025
Next SEC filing: 16 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Nancy E. Denyes, as Attorney-in-Fact

Key filing fact

Eric Benevich filed Form 4 for aTYR PHARMA INC (ATYR) on 02 May 2025.

Key facts

This page summarizes Eric Benevich's Form 4 filing for aTYR PHARMA INC (ATYR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 May 2025, 17:18.

Change

Previous filing in this sequence was filed on 14 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001643653 Primary reporting owner

BENEVICH ERIC

Relationship: Director
Address: 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO
Signature: /s/ Nancy E. Denyes, as Attorney-in-Fact
Signature date: 02 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATYR transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +50,000
Change %
Price: $0.000000
Shares after: 50,000
Date: 01 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $3.34
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.